Recent Articles from Investor Brand Network

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

Disseminated on behalf of Planet Ventures Inc. (CSE: PXI) (OTC: PNXPF) (FSE: P6U) and may include paid advertising.

Versus Systems (NASDAQ: VS) developed and operates a patented earned-rewards platform that enables brands, sports teams, broadcasters and content creators to embed games and real-world prizes directly into digital and live experiences. A recent article discussing this reads, “The platform encourages participation through interactive challenges, contests and reward-based activities… Versus has engaged more than 10 million consumers through campaigns deployed across sports, entertainment and corporate environments. The company’s technology has been used alongside major brands, sports franchises and media organizations, demonstrating how gamification is increasingly becoming part of broader marketing strategies.”

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

TechForce Robotics, Inc. (“TechForce”), a subsidiary of Nightfood Holdings, Inc. (OTCQB: NGTF), is extending the boundaries of service robotics commercialization, moving its AI-powered automation platforms from pilot deployments into industrial-scale, revenue-generating fleet systems. Reputed for developing autonomous service robots created for logistics, hospitality, healthcare, and commercial settings, the company is now advancing toward full-scale commercialization through integrated manufacturing and deployment partnerships, opening the door to a new era of scalable Robotics-as-a-Service Provider (“RaaSP”) adoption across enterprise markets ( ibn.fm/KnktY ).

New research suggests that crypto use in the U.S . is increasingly shaped by political affiliation, while a far larger divide continues to exist between men and women.

Disseminated on behalf of Onco-Innovations Ltd. (CBOE CA: ONCO) (OTCQB: ONNVF) and may include paid advertising.

Professionals and executives from clinical, legal, regulatory, and operational sectors are invited to attend the 7th Clinical Trial Agreements Summit, to be held on Aug. 27-28, 2026, at the Sonesta Philadelphia Rittenhouse Hotel in Philadelphia, Pennsylvania.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

The failure of the U.S. Congress to extend the public subsidies that were helping millions of Americans to access public health insurance has resulted in millions losing their health coverage, deepened inequality and increased financial hardship for the most affected, according to Oxfam America and Human Rights Watch.

Uruguay has fundamentally reshaped its energy future as a global energy crisis rages on. Today, nearly all electricity powering this nation comes from wind, solar, hydropower, and biomass, a dramatic shift from two decades ago when energy crises plagued the country. The transformation has delivered measurable benefits across the economy, and international observers are studying how Uruguay engineered this change so effectively.

The European Union is reportedly considering new tariffs on plug-in hybrid electric vehicles (PHEVs) imported from China. The move comes as European officials continue to examine the growing presence of Chinese automakers in the region and the impact their vehicles may have on local manufacturers.

The medical community has for long relied on antibiotic prophylaxis, the practice of prescribing antibiotics to safeguard at-risk individuals from bacterial infections. However, a new publication has sounded the alarm on the widespread use of these “just in case” treatments due to their risk of driving antibiotic resistance.

The United States’ clean energy transition is facing new challenges as policy priorities increasingly favor fossil fuels over renewable energy. One of the most visible examples is the renaming of the National Renewable Energy Laboratory, a globally recognized center for renewable energy research.

Researchers at the Massachusetts Institute of Technology have weighed in on a long-running debate over whether battery-powered cars truly pollute less than gasoline vehicles . Skeptics often point to the resources needed to mine EV battery materials, while supporters argue that avoiding tailpipe emissions makes electric cars cleaner overall.

Just days after its public debut, Anthropic’s most advanced AI system was removed from circulation following intervention by the Trump administration, which cited national security concerns tied to a reported security bypass.

Nightfood Holdings (OTCQB: NGTF) doing business as TechForce Robotics, announced it has signed a non-binding letter of intent to acquire a 51% controlling interest in Taiwan-based Jiun Jiang Enterprise Co. Ltd., a manufacturer of semiconductor automation, advanced packaging equipment, robotics and intelligent manufacturing systems. The proposed all-stock transaction would make JJ Enterprise a majority-owned operating subsidiary, with the purchase price tied to audited financial performance under U.S. GAAP and subject to due diligence, definitive agreements and other closing conditions.

American Fusion (OTC: AMFN) announced it has finalized the comprehensive testing protocol for its 5MW Pre-Production Texatron(TM) Fusion Engine(TM), establishing the engineering and scientific framework that will guide validation of the company’s fusion energy platform. The protocol includes plasma density and temperature measurements, neutron monitoring, spectroscopy, electrical power analysis and calibration procedures, while also providing for independent scientific observation, public release of testing video and third-party evaluation of results as the company advances toward commercial validation.

Earth Science Tech (OTC: ETST), a strategic holding company that acquires and manages a diverse portfolio of businesses, recently announced the financial results for the full fiscal year that ended on March 31, 2026 ( https://ibn.fm/xRoIz ).

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

HeartBeam (NASDAQ: BEAT) announced a strategic reorganization aimed at accelerating execution, expanding global market reach and improving capital efficiency as it advances commercialization of its cardiac monitoring technology. Under the new structure, Founder and President Branislav Vajdic, Ph.D., and Executive Chairman Rich Ferrari will lead focused implementation teams designed to streamline decision-making, improve accountability and reduce costs. As part of the transition, former CEO Robert Eno will move into a consulting role.

Greenland Mines (NASDAQ: GRML) announced it has completed a three-day, multidisciplinary planning workshop for its Skaergaard Precious and Critical Metals Project in southeast Greenland, bringing together more than 15 international experts from GTK Mintec, the Geological Survey of Finland, SLR Consulting, WSP Denmark and other technical specialists. The June 22-24 sessions focused on advancing understanding of the orebody and processing pathways, planning 2026 drilling, sampling and environmental programs and establishing a roadmap toward an Initial Assessment (“IA”) or Preliminary Economic Assessment (“PEA”) and future development.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Versus Systems (NASDAQ: VS), a leading provider of gamification and audience engagement technology, has received new attention from the investment community following the initiation of research coverage by Zacks Investment Research, which highlighted the company’s recent operational progress and future growth opportunities ( https://nnw.fm/VDBzc ).

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

Disseminated on behalf of Canamera Energy Metals Corp. (CSE: EMET) (OTCQB: EMETF) and may include paid advertising.

MindWave Innovations (NYSE American: APUS) is positioning as bitcoin moves deeper into corporate finance and many companies contemplate not whether digital assets belong on the balance sheet but rather how they can be held, reported and deployed responsibly. “MindWave provides a secure and compliant gateway to digital assets through insured custody solutions, AI-enabled yield strategies and transparent reporting systems. That combination is important because corporate adoption depends not only on asset exposure but also on the ability to demonstrate that treasury activity is documented and aligned with the expectations of directors, auditors and shareholders,” reads a recent article.

Oncotelic Therapeutics (OTCQB: OTLC) was featured in a recent article that discussed the company’s efforts to move beyond its roots as a clinical-stage biotechnology company into the quickly expanding intersection of artificial intelligence and industrial automation. The publication reads, “Through two closely aligned announcements, the firm has unveiled a strategic partnership with TechForce Robotics, which positions it to commercialize a next-generation, AI-enhanced platform created for regulated pharmaceutical environments… At the core of this pivot is Oncotelic’s proprietary PDAOAI platform, an AI-driven system designed to improve compliance, monitoring, and operational intelligence. By integrating this innovation with TechForce Robotics’ hardware and manufacturing expertise, the companies aim to deliver a GMP-compliant robotics solution capable of automating critical workflows in pharmaceutical production and laboratory settings.”

VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has announced new in vitro proof-of-concept data supporting its BiTAC-ADC platform, a technology designed to improve the selectivity of antibody-drug conjugates in cancer treatment. The announcement comes as the company prepares to engage with potential pharmaceutical and biotechnology partners during the BIO International Convention 2026 in San Diego ( https://nnw.fm/APy2D ).

Energy, Oil & Gas Magazine profiles CEO Robert Price as company prepares for October 2026 exploration campaign in East Greenland

Artificial intelligence has become a part of everyday life for millions of people. Tools such as ChatGPT, Claude, and other AI assistants are now used for learning, work, research, and finding information online. While these technologies offer many benefits, a new study suggests that relying too much on AI may have negative effects on critical thinking and independent judgment.

Researchers from King’s College London and McMaster University have made a discovery that could fundamentally change how doctors treat brain cancer. The team identified a molecular pathway that appears critical to cancer’s ability to migrate to the brain.

On Monday, precious metal prices ticked upwards. Gold reached $4,362 an ounce, marking gains of approximately 3.4%. Silver’s price hit $71.2 an ounce, a rally of about 4.7%. We look at some of the key factors that are driving this rally in precious metal prices as this week progresses.

BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors, a category of drugs that work by blocking cancer cells’ capacity to fix their own damaged DNA, are growing well beyond the poly ADP ribose polymerase (“PARP”) inhibitor that first defined the category. DDR-inhibiting therapies generated an estimated $7 billion-plus in worldwide sales in 2025, and the wider oncology, diagnostics and precision medicine markets are expected to approach about $750 billion by 2030. A fresh wave of inhibitor classes is now taking shape as the next major opportunity. Standing at the leading edge of this shift is Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) ( Profile ), a Canadian clinical-stage oncology company developing ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target a DNA repair enzyme that participates in several distinct repair pathways. As the industry works toward the next generation of synthetic lethality assets, Onco-Innovations occupies a distinctive niche as it builds out its position within the biopharmaceutical and biotechnology space, alongside other established companies such as Merck & Co. Inc. (NYSE: MRK), Pfizer Inc. (NYSE: PFE), GSK plc (NYSE: GSK) and Gilead Sciences Inc. (NASDAQ: GILD), all of which are focused on…

BioMedWire Editorial Coverage: Multiple sclerosis (“MS”) gradually strips people of command over their own bodies, advancing steadily with no available cure. More than 2.9 million people across the globe are currently living with the disease. But even with generations of scientific study and research, every approved treatment still falls short of one essential objective: bringing the disease to a complete stop. Existing therapies can slow its advance, but none can halt it outright. That shortfall translates into a future of mounting disability for millions of MS sufferers. Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) ( Profile ) is determined working to change that outcome. The company is developing Lucid-MS, a patented, first-in-class drug candidate that approaches the disease from an entirely different angle by directly targeting the myelin sheath that MS destroys; the potential treatment is now preparing to move into phase 2 clinical trials. Quantum BioPharma stands among a group of companies pursuing therapies for neurological, autoimmune and immune-mediated conditions, a group that also includes Novartis AG (NYSE: NVS), Merck & Co. Inc. (NYSE: MRK), TG Therapeutics Inc. (NASDAQ: TGTX) and…

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform offering a quicker and easier path to home ownership, was added as a member of the Russell Microcap Index, marking a notable milestone for the digital mortgage company as it attempts to scale its technology-driven lending platform during one of the most challenging housing finance environments in years.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

Cardio Diagnostics Holdings (NASDAQ: CDIO), an AI-powered precision cardiovascular medicine company, announced that Atlas Healthcare Physicians, an independent physician association serving managed care populations across Los Angeles and Orange counties, will provide coverage for the company’s Epi+Gen CHD(TM) and PrecisionCHD(TM) tests for eligible members with prior authorization. The coverage expands access to physician-ordered blood tests designed to assess coronary heart disease risk and support diagnosis and personalized treatment planning.

Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports vehicles and mobility solutions, announced it has terminated its previously proposed acquisition of FST Development Company Limited. The company said that after reviewing its strategic priorities, capital allocation plans and recent development progress, it elected not to proceed with the transaction or the previously contemplated stock-based acquisition structure.

Gaxos.ai (NASDAQ: GXAI) a developer of artificial intelligence applications across multiple industries, announced the completion of the sale of its gaming assets, including its portfolio of mobile games and Gaxos Gaming Labs, to privately held Game Foundry AI. The all-stock transaction was valued at approximately $1.76 million and is intended to support Gaxos’ strategy of focusing resources on its revenue-generating AI businesses and higher-margin commercial opportunities.

Rail Vision (NASDAQ: RVSN) (FSE: C80), a developer of AI-powered railway safety and sensing systems, announced the successful completion of ShuntingYard field testing with Israel Railways. The evaluation was conducted during daily rail yard operations, where locomotive drivers and operational personnel assessed the system’s ability to detect and classify potential obstacles in real time under active and challenging operating conditions. According to the company, feedback from Israel Railways personnel was positive, highlighting the system’s ability to enhance situational awareness during shunting activities.

This article has been disseminated on behalf of Onco-Innovations Limited and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

This article has been disseminated on behalf of Silvercorp Metals and may include paid advertising.

This article has been disseminated on behalf of Helus Pharma and may include paid advertising.

Greenland Mines (NASDAQ: GRML) is focused on the exploration and development of mineral assets in Greenland. Through its mining division, the company is advancing the Skaergaard Project in southeast Greenland while also pursuing the acquisition of the Sarfartoq rare earth project in southwest Greenland. Together, these assets provide exposure to precious metals, critical metals and rare earth elements within a jurisdiction that has attracted growing interest as governments and industries seek to diversify strategic mineral supply chains.

VERAXA Biotech (NASDAQ: VRXA) an emerging developer of novel cancer therapies, announced it has expanded its laboratory footprint at its existing research and development site in Heidelberg, Germany, under a previously executed long-term lease agreement. The additional space will support planned growth of the company’s R&D team, installation of new laboratory equipment and completion of infrastructure needed to advance future development activities.

Wearable Devices (NASDAQ: WLDS) announced the release of a new white paper outlining how its Mudra neural interface platform could serve as an “intent layer” for agentic artificial intelligence, augmented reality and robotics applications. The paper introduces the company’s proprietary Large MUAP Model (“LMM”), which translates wrist-based nerve and muscle signals into machine-readable “neural tokens” designed to improve intent recognition, reduce user setup requirements and enhance system performance as additional data is collected.

Datavault AI (NASDAQ: DVLT) through its Acoustic Sciences division’s WiSA Technologies, announced that its WiSA E Enterprise wireless audio module has been integrated into Goldhorn’s new Goho LS7 2.0 and 5.1 home audio and karaoke systems. The systems feature 4K Ultra HD projectors and are designed to deliver high-definition stereo and immersive 5.1 surround sound using WiSA’s wireless audio transmission technology, with products now available in China.

This article has been disseminated on behalf of Wheaton Precious Metals Corp. and may include paid advertising.

Disseminated on behalf of ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) and may include paid advertising.

The search for new cancer therapies has traditionally focused on discovering entirely new drug candidates. While this approach has produced important breakthroughs, it is also expensive, time-consuming and carries a high risk of failure. Increasingly, researchers and biotechnology companies are exploring a complementary strategy: improving the way existing drugs are delivered to patients.

Hallmark Venture Group (OTC: HLLK) announced the completion of a strategic transaction that transforms the company from a shell entity into an operating drone technology business focused on unmanned aerial systems, defense technology and commercial applications. Through the acquisition of a worldwide drone technology platform from South Korea-based Sundori Drone Co., Ltd., the company obtained proprietary technology, software, AI and machine-learning assets, technical documentation and commercialization rights tied to 12 Korean patents, while also securing ongoing engineering support and collaboration agreements.

Gold continues to strengthen its position within the global financial system, with central banks signaling a growing commitment to the precious metal despite record-high prices. According to the latest survey on Central Bank Gold Reserves by the World Gold Council, confidence in gold remains exceptionally strong among reserve managers globally.

Global electric vehicle deployment has accelerated far beyond initial industry projections and forecasts . EV sales reached approximately 21 million units in 2025, reflecting impressive growth trajectories across all markets worldwide. Market penetration shifted dramatically from minimal shares to dominant positions spanning multiple continents.

Researchers at Washington University (WashU) Medicine have conducted a small clinical trial testing a new vaccine against glioblastoma . The formulation was administered to nine patients who had undergone surgery and chemo-radiation therapy to remove their tumors. The results of this study show promise in extending tumor-free survival for a disease that is currently hard to treat.

If you have seen the buildings housing data centers, you may be wondering why the timelines from data center planning to commissioning take years while similarly sized warehouses require weeks or a few months to construct. We explore some specific reasons why setting up a data center can stretch several years before the facility comes online.

A new report published by Wood Mackenzie, a global research company, reveals that producers of metals like aluminum and copper are seeing a huge uptick in the demand of these metals beyond what current estimates suggest.

Consumer electricity expenses dropped significantly in Spain while most European households faced rising power bills following the Middle Eastern conflict disrupting global energy supplies and shipping routes. Monthly cost reductions averaged approximately $11 per household due to renewable infrastructure progressively reducing fossil fuel dependence.

Fresh details have emerged about a series of arson attacks linked to properties associated with UK Prime Minister Sir Keir Starmer, with reports indicating that a Russian-directed network allegedly promised cryptocurrency payments to those involved.

Binance, one of the world’s largest cryptocurrency exchanges, is facing uncertainty in Europe as a key regulatory deadline draws closer. Reports suggest that the company’s application for a license under the European Union’s Markets in Crypto-Assets (MiCA) framework may be rejected in Greece. If that happens and Binance fails to secure approval elsewhere, it could lose the ability to offer its services across the EU starting in July.

Greenland Energy (NASDAQ: GLND) is positioning itself at the intersection of one of the Arctic’s most compelling economic opportunities. Through the company’s Jameson Project in East Greenland, it is pursuing resource exploration in an area that has long attracted geological interest but has seen only limited development. As Greenland seeks to improve its economic future and cut down dependence on external financial support, projects like Jameson highlight the critical role responsible resource development can play in building long-term prosperity.

Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) announced its inclusion in a BioMedWire editorial examining the growing market for DNA Damage Response inhibitor (“DDRi”) therapies and the next generation of cancer treatments targeting DNA repair pathways. The article highlights the company’s lead candidate, ONC010(TM), a nanoparticle-encapsulated PNKP inhibitor designed to target a key DNA repair enzyme involved in multiple repair mechanisms, positioning Onco-Innovations among emerging developers seeking to advance new synthetic lethality approaches in precision oncology.

Safe Pro Group (NASDAQ: SPAI), has released a demonstration video highlighting its new RoadSight capability, which applies the company’s patented SPOTD (Safe Pro Object Threat Detection) technology to autonomous Unmanned Ground Vehicles (“UGVs”). The video illustrates how Safe Pro’s AI-powered computer vision platform is designed to detect landmines, unexploded ordnance and other explosive threats in real time, complementing the company’s recently announced $1.3 million U.S. Army subcontract to integrate the technology into autonomous UGVs.

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.

American Fusion (OTC: AMFN) provided an update after Chief Technology Officer Dr. John Brandenburg presented the company’s Texatron(TM) Fusion Engine(TM) platform at the IEEE International Conference on Plasma Science (“ICOPS”) 2026 on June 22. Management reported strong engagement from researchers and industry professionals attending the conference, with extensive follow-up discussions surrounding the company’s compact fusion technology and its potential role in future energy production.

This article has been disseminated on behalf of Energy Fuels Inc. and may include paid advertising.

Safe Pro Group (NASDAQ: SPAI), announced it has received a $1.3 million U.S. Army subcontract from a leading defense prime contractor to integrate its proprietary AI-powered real-time threat detection technology into autonomous Unmanned Ground Vehicles (“UGVs”). The project will incorporate Safe Pro’s computer vision and machine learning pipeline onboard UGVs to detect explosive threats in real time while supporting on-the-move military operations.

Blockchain Futurist Conference is set to return to Toronto on July 21–22, 2026, bringing together institutions and digital asset leaders to explore emerging advances in finance. The conference will focus on key topics including digital asset regulation, institutional adoption, stablecoins, tokenization, artificial intelligence, compliance, decentralized finance, and digital identity. Featured sessions will include discussions with representatives from organizations such as Bloomberg, JPMorgan, Mastercard, and other industry leaders. Sponsors and partners including AiraPay and Stablecorp will showcase innovations in payments and stablecoin technology, while special programming from organizations such as House of Intelligence and Invest Hong Kong will shine the spotlight on emerging trends in AI, privacy, and global digital asset adoption.

Heart disease has held the grim distinction of being the leading cause of death in the United States for decades, and despite advances in medicine, the problem is getting worse, not better. According to the American Heart Association (“AHA”), cardiovascular disease accounted for more than 940,000 deaths in the United States in 2022, maintaining its position as the nation’s number one killer. Into that persistent and costly healthcare burden steps Cardio Diagnostics Holdings (NASDAQ: CDIO), a Chicago-based precision cardiovascular medicine company that is applying artificial intelligence, epigenetics and genetics to a problem that traditional diagnostic tools have never fully solved: detecting coronary heart disease, including forms that standard methods routinely miss, from a simple blood draw.

American Fusion(TM) (OTC: AMFN), a developer of next-generation fusion energy technologies, recently announced another step in its commercialization strategy with the filing of a new patent application covering innovations expected to be incorporated into future commercial versions of its Texatron(TM) Fusion Engine(TM) platform. According to the company, the application covers architectural and operational innovations currently being evaluated for future generations of the Texatron(TM) Fusion Engine(TM) following completion of Version 9 testing ( https://ibn.fm/57OcR ).

This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising.